Sign In
Buy SRTS
$2.84
+0 (+0%)
At Close: Jun 03, 2026
First veterinary commercial sale of the SRT-100 outside the U.S. BOCA RATON, Fla., May 09, 2024 (GLOBE NEWSWIRE) -- Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in hig
Sensus Healthcare to Host First Quarter 2024 Financial Results and Business Update Conference Call on Thursday, May 9, 2024
04:05pm, Thursday, 18'th Apr 2024
BOCA RATON, Fla. , April 18, 2024 (GLOBE NEWSWIRE) -- Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in highly effective, non-invasive treatments for both oncological an
Sensus Healthcare to Participate in the 36th Annual Roth Conference
04:05pm, Thursday, 14'th Mar 2024
Management will discuss its new “Fair Deal Agreement” for its SRT-100 Vision™ IG-SRT in one-on-one meetings in Dana Point, California on March 18th and 19th
Sensus Healthcare Launches “Fair Deal Agreement” for its SRT-100 Vision™ at the American Academy of Dermatology Annual Meeting
08:00am, Wednesday, 13'th Mar 2024
New shared service contract expands the unmatched clinical results achieved with IG-SRT to a broader base of prospective customers
3 Stocks to Buy That Are Up 100% or More in 2024
02:02pm, Sunday, 25'th Feb 2024
While people tend to avoid price hikes, certain stocks up 100% this year just might provide an exception to the rule. Basically, not even two months have passed by.
New Strong Buy Stocks for February 12th
07:26am, Monday, 12'th Feb 2024
MSGE, AZEK, XRX, AMSC and SRTS have been added to the Zacks Rank #1 (Strong Buy) List on February 12, 2023.
Sensus Healthcare, Inc. (SRTS) Q4 2023 Earnings Call Transcript
09:59pm, Thursday, 08'th Feb 2024
Sensus Healthcare, Inc. (SRTS) Q4 2023 Earnings Call Transcript
Sensus Healthcare, Inc. (SRTS) Q4 Earnings and Revenues Top Estimates
06:51pm, Thursday, 08'th Feb 2024
Sensus Healthcare, Inc. (SRTS) came out with quarterly earnings of $0.26 per share, beating the Zacks Consensus Estimate of $0.12 per share. This compares to earnings of $0.17 per share a year ago.
Sensus Healthcare Reports Fourth Quarter and Full Year 2023 Financial Results
04:05pm, Thursday, 08'th Feb 2024
Fourth quarter revenues of $12.6 million up three-fold sequentially, reflect ongoing customer adjustment to macroeconomic conditions Introduces recurring revenue model for the SRT-100 Vision ™ (IG-S
Earnings Preview: Sensus Healthcare, Inc. (SRTS) Q4 Earnings Expected to Decline
11:06am, Thursday, 01'st Feb 2024
Sensus Healthcare, Inc. (SRTS) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Sensus Healthcare Announces Retirement of Director Samuel O'Rear
08:00am, Thursday, 01'st Feb 2024
BOCA RATON, Fla., Feb. 01, 2024 (GLOBE NEWSWIRE) -- Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in highly effective, non-invasive, minimally-invasive and cost-effec
BOCA RATON, Fla. , Jan. 30, 2024 (GLOBE NEWSWIRE) -- Sensus Healthcare, Inc. (Nasdaq: SRTS), a medical device company specializing in highly effective, non-invasive treatments for both oncological and
Sensus Healthcare Announces Preliminary 2023 Revenue Exceeds $23 Million
08:00am, Tuesday, 23'rd Jan 2024
Ships more than 60 SRT units in 2023 To report full financial results and hold conference call on February 8th
Sensus Healthcare, Inc. (SRTS) Q3 2023 Earnings Call Transcript
07:09pm, Thursday, 09'th Nov 2023
Sensus Healthcare, Inc. (SRTS) Q3 2023 Earnings Call Transcript
Sensus Healthcare Reports Third Quarter 2023 Financial Results
04:05pm, Thursday, 09'th Nov 2023
Revenues of $3.9 million reflect seasonality and macroeconomic conditions Conference call begins at 4:30 p.m. Eastern time today BOCA RATON, Fla.
